HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noah Kiwanuka Selected Research

Tuberculosis (Tuberculoses)

2/2024Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
12/2021Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
7/2021Heme oxygenase-1 and neopterin plasma/serum levels and their role in diagnosing active and latent TB among HIV/TB co-infected patients: a cross sectional study.
6/2021Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda-patient and health worker perspectives.
12/2020Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda.
12/2014Prevalence of Mycobacterium bovis skin positivity and associated risk factors in cattle from western Uganda.
7/2014Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Noah Kiwanuka Research Topics

Disease

13Infections
02/2024 - 01/2005
7HIV Infections (HIV Infection)
02/2024 - 04/2004
7Tuberculosis (Tuberculoses)
02/2024 - 07/2014
6Malaria
01/2018 - 05/2014
6Disease Progression
01/2018 - 03/2008
5Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2020 - 12/2004
4Acquired Immunodeficiency Syndrome (AIDS)
01/2023 - 07/2010
3COVID-19
02/2024 - 01/2021
3Schistosomiasis (Bilharziasis)
02/2023 - 11/2018
3Bacterial Vaginosis
11/2018 - 02/2011
2Hepatitis B
02/2023 - 01/2023
2Cicatrix (Scar)
01/2023 - 01/2022
2Keloid
01/2023 - 01/2022
2Anemia
01/2022 - 01/2020
2Syphilis
11/2021 - 01/2005
2Latent Tuberculosis
01/2021 - 01/2018
2Reinfection
01/2020 - 01/2014
2Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 01/2019
2Hemorrhage
01/2020 - 01/2019
2Neoplasms (Cancer)
01/2019 - 10/2018
2HIV Seropositivity
09/2015 - 02/2011
2Ulcer
06/2012 - 11/2009
1Respiratory Insufficiency (Respiratory Failure)
02/2024
1Human Influenza (Influenza)
02/2024
1Lymphopenia (Lymphocytopenia)
02/2024
1Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2024
1Respiratory Tract Infections (Respiratory Tract Infection)
02/2024
1Schistosomiasis mansoni
02/2023
1Viremia
01/2023
1Hypertrophic Cicatrix (Hypertrophic Scar)
01/2022
1Latent Infection
01/2021
1Thrombocytopenia (Thrombopenia)
01/2020
1Cryptococcal Meningitis
01/2019
1Necrosis
11/2018
1Eosinophilia
11/2018
1Drug-Related Side Effects and Adverse Reactions
10/2018
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018
1Virus Diseases (Viral Diseases)
12/2017
1Yellow Fever
07/2014
1Rheumatic Heart Disease (Rheumatic Heart Diseases)
02/2014
1Rheumatic Fever (Acute Articular Rheumatism)
02/2014
1Communicable Diseases (Infectious Diseases)
01/2013

Drug/Important Bio-Agent (IBA)

4rifapentine (Priftin)FDA Link
02/2024 - 12/2020
4Isoniazid (Ftivazide)FDA LinkGeneric
02/2024 - 12/2020
4VaccinesIBA
02/2023 - 03/2008
4AntigensIBA
02/2023 - 02/2014
4Tuberculin (PPD)IBA
07/2021 - 12/2014
4Contraceptive Agents (Contraceptives)IBA
01/2020 - 07/2010
4Antimalarials (Antimalarial Agents)IBA
01/2018 - 02/2016
3Hemoglobins (Hemoglobin)IBA
01/2022 - 01/2019
2gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA
02/2023 - 01/2023
2GoldIBA
07/2021 - 01/2018
2CytokinesIBA
11/2018 - 04/2009
2Coloring Agents (Dyes)IBA
11/2011 - 02/2011
2Lipopolysaccharide ReceptorsIBA
04/2011 - 04/2009
1Interferon Type IIBA
02/2024
1Lymphotoxin-alpha (Lymphotoxin)IBA
02/2024
1Platelet-Derived Growth FactorIBA
02/2024
1Proteins (Proteins, Gene)FDA Link
02/2024
1Interleukin-7 (Interleukin 7)IBA
02/2024
1Interleukin-15 (Interleukin 15)IBA
02/2024
1ProteomeIBA
02/2024
1InflammasomesIBA
02/2024
1mesoglycanIBA
01/2022
19 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
12/2021
1Blood Glucose (Blood Sugar)IBA
11/2021
1Interferon-gamma (Interferon, gamma)IBA
07/2021
1NeopterinIBA
07/2021
1N,N-dimethyl-4-anisidine (DMPA)IBA
02/2021
1BCG VaccineFDA Link
01/2021
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2021
1InterleukinsIBA
11/2018
1Biomarkers (Surrogate Marker)IBA
11/2018
1Prostate-Specific Antigen (Semenogelase)IBA
11/2018
1Auranofin (Ridaura)FDA Link
01/2018
1IntegrinsIBA
01/2018
1Monoclonal AntibodiesIBA
01/2018
1phosphine (phosphane)IBA
01/2018
1ArtesunateIBA
12/2017
1artemisinin (artemisinine)IBA
12/2017
1Quinine (Quinson)FDA Link
12/2017
1WastewaterIBA
12/2017
1EnzymesIBA
09/2015
1ImmunosorbentsIBA
09/2015
1artenimol (dihydroartemisinin)IBA
05/2014
1piperaquineIBA
05/2014
1HLA-DR Antigens (HLA-DR)IBA
02/2014

Therapy/Procedure

16Therapeutics
02/2024 - 03/2008
6Condoms (Condom)
01/2020 - 06/2008
6Male Circumcision
01/2014 - 12/2004
2Self-Testing
01/2022 - 01/2021
2Blood Transfusion (Blood Transfusions)
01/2020 - 10/2018
2Art Therapy
10/2015 - 01/2013
2Hormonal Contraception
02/2011 - 07/2010
1Immunotherapy
02/2024
1Prenatal Care (Care, Prenatal)
01/2022
1Drug Therapy (Chemotherapy)
01/2019
1Platelet Transfusion (Blood Platelet Transfusions)
01/2019
1Injections
11/2018
1Retention in Care
10/2018